Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2020

29.03.2020 | Epidemiology

Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma

verfasst von: Wei Liu, Wei Li, Ziyao Li, Lei Shi, Peng Zhao, Zihong Guo, Jiawei Tian, Zhenzhen Wang

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Sclerosing adenosis (SA) is a benign lesion with complicated pathological components and could mimic breast carcinoma in both clinical palpation and medical imaging findings. The present study was conducted to assess the value of ultrasound (US) characteristics in diagnosing SA and their differentiation from breast carcinoma.

Methods

We retrospectively reviewed the medical records of 305 women (347 lesions) with invasive ductal carcinoma (IDC) and 54 women with single SA lesion, who had breast excision between April 2016 and July 2018. US BI-RADS atlas and elastography were applied and their associated characteristics were compared between SA and IDC.

Results

The mean age of SA was younger than that of IDC (43.6 ± 7.4 vs 53.2 ± 10.3, P < 0.001). Compared to IDC, SA had more frequency of parallel orientation (94.44% vs 71.76%, P < 0.001) and circumscribed margin (48.15% vs 4.90%, P < 0.001), less frequency of irregular shape (64.81% vs 95.97%, P < 0.001), hypoechoic echotexture (88.89% vs 98.27%, P = 0.002), calcification (12.96% vs 55.04%, P < 0.001), and posterior acoustic changes (3.70% vs 53.89%, P < 0.001) or associated features (architectural distortion, 3.70% vs 59.65%, P < 0.001; duct changes, 18.52% vs 63.40%, P < 0.001). Vascularity absence was more common in SA compared to IDC (35.19% vs 6.63%, P < 0.001). And the elasticity score was lower in SA (2.38 ± 0.60 vs 3.91 ± 0.81, P < 0.001). After adjusting for age, we found spiculated margin, posterior shadowing, calcification, architectural distortion, and vascularity could independently identify the differences between these two entities. After involving elasticity score, the calcification and vascularity could still be independent indicators for differential diagnosis.

Conclusion

Understanding SA imaging features will enable radiologists to communicate results to the referring physician consistently, which could benefit a reliable assessment and specific management recommendations. A systematic evaluation of the US BI-RADS atlas together with breast elastography may be a powerful tool to identify SA and differentiate it from breast cancer.
Literatur
1.
Zurück zum Zitat Santen RJ, Mansel R (2005) Benign breast disorders. N Engl J Med 353(3):275–285CrossRef Santen RJ, Mansel R (2005) Benign breast disorders. N Engl J Med 353(3):275–285CrossRef
2.
Zurück zum Zitat Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC (2014) Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat 144(1):205–212CrossRef Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC (2014) Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat 144(1):205–212CrossRef
3.
Zurück zum Zitat DiPiro PJ, Gulizia JA, Lester SC, Meyer JE (2000) Mammographic and sonographic appearances of nodular adenosis. AJR Am J Roentgenol 175(1):31–34CrossRef DiPiro PJ, Gulizia JA, Lester SC, Meyer JE (2000) Mammographic and sonographic appearances of nodular adenosis. AJR Am J Roentgenol 175(1):31–34CrossRef
4.
Zurück zum Zitat Nielsen NS, Nielsen BB (1986) Mammographic features of sclerosing adenosis presenting as a tumour. Clin Radiol 37(4):371–373CrossRef Nielsen NS, Nielsen BB (1986) Mammographic features of sclerosing adenosis presenting as a tumour. Clin Radiol 37(4):371–373CrossRef
5.
Zurück zum Zitat Gunhan-Bilgen I, Memis A, Ustun EE, Ozdemir N, Erhan Y (2002) Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation. Eur J Radiol 44(3):232–238CrossRef Gunhan-Bilgen I, Memis A, Ustun EE, Ozdemir N, Erhan Y (2002) Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation. Eur J Radiol 44(3):232–238CrossRef
6.
Zurück zum Zitat Chen YL, Chen JJ, Chang C, Gao Y, Wu J, Yang WT, Gu YJ (2017) Sclerosing adenosis: ultrasonographic and mammographic findings and correlation with histopathology. Mol Clin Oncol 6(2):157–162CrossRef Chen YL, Chen JJ, Chang C, Gao Y, Wu J, Yang WT, Gu YJ (2017) Sclerosing adenosis: ultrasonographic and mammographic findings and correlation with histopathology. Mol Clin Oncol 6(2):157–162CrossRef
7.
Zurück zum Zitat Makki J (2015) Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin Med Insights Pathol 8:23–31PubMedPubMedCentral Makki J (2015) Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin Med Insights Pathol 8:23–31PubMedPubMedCentral
8.
Zurück zum Zitat Mendelson EB, Böhm-Vélez M, Berg WA et al (2013) ACR BI-RADS® ultrasound. ACR BI-RADS® atlas, breast imaging reporting and data system. American College of Radiology, Reston, VA Mendelson EB, Böhm-Vélez M, Berg WA et al (2013) ACR BI-RADS® ultrasound. ACR BI-RADS® atlas, breast imaging reporting and data system. American College of Radiology, Reston, VA
9.
Zurück zum Zitat Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X (1991) Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 13(2):111–134CrossRef Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X (1991) Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 13(2):111–134CrossRef
10.
Zurück zum Zitat Adler DD, Carson PL, Rubin JM, Quinn-Reid D (1990) Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol 16(6):553–559CrossRef Adler DD, Carson PL, Rubin JM, Quinn-Reid D (1990) Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol 16(6):553–559CrossRef
11.
Zurück zum Zitat Wang Z, Liu N, Zhang L, Li X, Han X, Peng Y, Dang M, Sun L, Tian J (2016) Real-time elastography visualization and histopathological characterization of rabbit atherosclerotic carotid arteries. Ultrasound Med Biol 42(1):176–184CrossRef Wang Z, Liu N, Zhang L, Li X, Han X, Peng Y, Dang M, Sun L, Tian J (2016) Real-time elastography visualization and histopathological characterization of rabbit atherosclerotic carotid arteries. Ultrasound Med Biol 42(1):176–184CrossRef
12.
Zurück zum Zitat Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW et al (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229–237CrossRef Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW et al (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229–237CrossRef
13.
Zurück zum Zitat Cichon MA, Degnim AC, Visscher DW, Radisky DC (2010) Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J Mammary Gland Biol Neoplasia 15(4):389–397CrossRef Cichon MA, Degnim AC, Visscher DW, Radisky DC (2010) Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J Mammary Gland Biol Neoplasia 15(4):389–397CrossRef
14.
Zurück zum Zitat Cho SH, Park SH (2013) Mimickers of breast malignancy on breast sonography. J Ultrasound Med 32(11):2029–2036CrossRef Cho SH, Park SH (2013) Mimickers of breast malignancy on breast sonography. J Ultrasound Med 32(11):2029–2036CrossRef
15.
Zurück zum Zitat Huang N, Chen J, Xue J, Yu B, Chen Y, Yang W, Shao Z, Wu J (2015) Breast sclerosing adenosis and accompanying malignancies: a clinicopathological and imaging study in a Chinese population. Medicine (Baltimore) 94(49):e2298CrossRef Huang N, Chen J, Xue J, Yu B, Chen Y, Yang W, Shao Z, Wu J (2015) Breast sclerosing adenosis and accompanying malignancies: a clinicopathological and imaging study in a Chinese population. Medicine (Baltimore) 94(49):e2298CrossRef
16.
Zurück zum Zitat Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE (2014) Breast cancer in China. Lancet Oncol 15(7):e279–289CrossRef Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE (2014) Breast cancer in China. Lancet Oncol 15(7):e279–289CrossRef
17.
Zurück zum Zitat Gill HK, Ioffe OB, Berg WA (2003) When is a diagnosis of sclerosing adenosis acceptable at core biopsy? Radiology 228(1):50–57CrossRef Gill HK, Ioffe OB, Berg WA (2003) When is a diagnosis of sclerosing adenosis acceptable at core biopsy? Radiology 228(1):50–57CrossRef
18.
Zurück zum Zitat Chen JH, Nalcioglu O, Su MY (2008) Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging 28(6):1499–1505CrossRef Chen JH, Nalcioglu O, Su MY (2008) Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging 28(6):1499–1505CrossRef
19.
Zurück zum Zitat Guray M, Sahin AA (2006) Benign breast diseases: classification, diagnosis, and management. Oncologist 11(5):435–449CrossRef Guray M, Sahin AA (2006) Benign breast diseases: classification, diagnosis, and management. Oncologist 11(5):435–449CrossRef
Metadaten
Titel
Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma
verfasst von
Wei Liu
Wei Li
Ziyao Li
Lei Shi
Peng Zhao
Zihong Guo
Jiawei Tian
Zhenzhen Wang
Publikationsdatum
29.03.2020
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05609-2

Weitere Artikel der Ausgabe 1/2020

Breast Cancer Research and Treatment 1/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.